Dynamic chromatin accessibility landscape changes following interleukin-1 stimulation.


Journal

Epigenetics
ISSN: 1559-2308
Titre abrégé: Epigenetics
Pays: United States
ID NLM: 101265293

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 4 8 2020
medline: 18 8 2021
entrez: 4 8 2020
Statut: ppublish

Résumé

Dynamic modifications of chromatin allow rapid access of the gene regulatory machinery to condensed genomic regions facilitating subsequent gene expression. Inflammatory cytokine stimulation of cells can cause rapid gene expression changes through direct signalling pathway-mediated transcription factor activation and regulatory element binding. Here we used the Assay for Transposase Accessible Chromatin with high-throughput sequencing (ATAC-seq) to assess regions of the genome that are differentially accessible following treatment of cells with interleukin-1 (IL-1). We identified 126,483 open chromatin regions, with 241 regions significantly differentially accessible following stimulation, with 64 and 177 more or less accessible, respectively. These differentially accessible regions predominantly correspond to regions of the genome marked as enhancers. Motif searching identified an overrepresentation of a number of transcription factors, most notably RelA, in the regions becoming more accessible, with analysis of ChIP-seq data confirmed RelA binding to these regions. A significant correlation in differential chromatin accessibility and gene expression was also observed. Functionality in regulating gene expression was confirmed using CRISPR/Cas9 genome-editing to delete regions that became more accessible following stimulation in the genes

Identifiants

pubmed: 32741307
doi: 10.1080/15592294.2020.1789266
pmc: PMC7889151
doi:

Substances chimiques

C1QTNF1 protein, human 0
Interleukin-1 0
Proteins 0
RELA protein, human 0
Transcription Factor RelA 0
I-kappa B Kinase EC 2.7.11.10
IKBKE protein, human EC 2.7.11.10
MMP13 protein, human EC 3.4.24.-
Matrix Metalloproteinase 13 EC 3.4.24.-

Banques de données

figshare
['10.6084/m9.figshare.12851675.v1']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-119

Subventions

Organisme : Versus Arthritis
ID : 19424
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : MR/P020941/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : JXR 10641
Pays : United Kingdom

Références

Genome Res. 2012 Jun;22(6):1015-25
pubmed: 22508765
Exp Cell Res. 2003 Aug 1;288(1):208-17
pubmed: 12878172
Mol Cell. 2018 Sep 6;71(5):825-840.e6
pubmed: 30100266
Sci Rep. 2018 Apr 24;8(1):6438
pubmed: 29691435
Nucleic Acids Res. 2019 Jan 8;47(D1):D100-D105
pubmed: 30445619
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Sci Rep. 2017 May 26;7(1):2451
pubmed: 28550296
Nat Genet. 2019 Oct;51(10):1494-1505
pubmed: 31570894
J Biol Chem. 2017 Feb 3;292(5):1625-1636
pubmed: 27956552
Nature. 2018 Feb 8;554(7691):239-243
pubmed: 29420474
J Physiol. 2016 Nov 1;594(21):6133-6146
pubmed: 27222093
Nat Methods. 2015 Apr;12(4):326-8
pubmed: 25730490
Sci Signal. 2010 Jan 19;3(105):cm1
pubmed: 20086235
Immunity. 2013 Dec 12;39(6):1003-18
pubmed: 24332029
Cell Rep. 2015 Feb 10;10(5):726-739
pubmed: 25660023
Nat Protoc. 2012 Sep;7(9):1728-40
pubmed: 22936215
EMBO J. 2020 Jan 2;39(1):e101533
pubmed: 31701553
PLoS Biol. 2018 Sep 10;16(9):e2006347
pubmed: 30199532
Nat Genet. 2017 Oct;49(10):1428-1436
pubmed: 28869592
Genome Res. 2016 Nov;26(11):1478-1489
pubmed: 27633323
Genes Dev. 2019 Sep 1;33(17-18):1159-1174
pubmed: 31371436
Virol Sin. 2016 Dec;31(6):457-465
pubmed: 28063014
Sci Rep. 2020 Jan 24;10(1):1169
pubmed: 31980739
J Biol Chem. 2015 Apr 24;290(17):11093-107
pubmed: 25773540
F1000Res. 2019 Feb 18;8:
pubmed: 30828429
Osteoarthritis Cartilage. 2005 Aug;13(8):697-708
pubmed: 15950496
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
Nat Rev Genet. 2016 Aug;17(8):487-500
pubmed: 27346641
Cell. 2013 Jan 17;152(1-2):157-71
pubmed: 23332752
Nat Genet. 2004 Oct;36(10):1065-71
pubmed: 15361872
Matrix Biol. 2019 Apr;77:87-100
pubmed: 30193893
Cell Signal. 2017 Apr;32:36-47
pubmed: 28089769
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Genome Biol. 2014 Dec 03;15(12):536
pubmed: 25608606
Nature. 2012 Feb 05;482(7385):390-4
pubmed: 22307276
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
BMC Genomics. 2013 Feb 15;14:105
pubmed: 23414147
Nat Rev Genet. 2019 Apr;20(4):207-220
pubmed: 30675018
Nat Genet. 2018 Mar;50(3):424-431
pubmed: 29379200
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nucleic Acids Res. 2009 Sep;37(17):5641-55
pubmed: 19625488
Gene. 2005 Jun 20;353(1):118-33
pubmed: 15939554
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Nature. 1999 Aug 19;400(6746):784-7
pubmed: 10466730
Sci Data. 2019 May 20;6(1):65
pubmed: 31110271
Osteoarthritis Cartilage. 2007 Apr;15(4):431-41
pubmed: 17097317
J Mol Med (Berl). 2016 May;94(5):583-96
pubmed: 26687115
Adv Exp Med Biol. 2014;809:13-31
pubmed: 25302363
Nucleic Acids Res. 2001 Nov 1;29(21):4361-72
pubmed: 11691923
Sci STKE. 2006 Oct 17;2006(357):re13
pubmed: 17047224
Cancer Res. 2013 Jul 15;73(14):4533-47
pubmed: 23687337
Nat Rev Genet. 2017 Sep;18(9):517-534
pubmed: 28555658
Front Immunol. 2014 Feb 25;5:71
pubmed: 24611065
Cell. 2009 Jul 10;138(1):114-28
pubmed: 19596239
Bioinformatics. 2008 Jul 1;24(13):1547-8
pubmed: 18467348
Mol Cell. 2014 Oct 23;56(2):219-231
pubmed: 25263595
J Biol Chem. 2012 Jan 27;287(5):3559-72
pubmed: 22158614
Rheumatol Int. 2006 Aug;26(10):900-3
pubmed: 16468044
EMBO J. 2012 Nov 28;31(23):4404-14
pubmed: 23103767
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
J Cell Sci. 2014 Jun 1;127(Pt 11):2383-90
pubmed: 24829146
Mol Cell. 2014 Jan 23;53(2):193-208
pubmed: 24389100
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8
pubmed: 19458158
J Exp Med. 2001 Jun 18;193(12):1351-9
pubmed: 11413190
J Biol Chem. 2006 Jul 7;281(27):18482-8
pubmed: 16684768
J Biol Chem. 2012 Jan 6;287(2):1576-87
pubmed: 22086915
Cell. 2013 Jan 31;152(3):642-54
pubmed: 23333102
Cytokine. 2015 Nov;76(1):25-37
pubmed: 26185894

Auteurs

Matt J Barter (MJ)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

Kathleen Cheung (K)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.
Faculty of Medical Sciences, Bioinformatics Support Unit, Newcastle University , Newcastle upon Tyne, UK.

Julia Falk (J)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

Andreas C Panagiotopoulos (AC)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

Caitlin Cosimini (C)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

Siobhan O'Brien (S)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

Karina Teja-Putri (K)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

Graham Neill (G)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

David J Deehan (DJ)

Department of Orthopaedics, Freeman Hospital, Orthopaedics , UK.

David A Young (DA)

Faculty of Medical Sciences, Skeletal Research Group, Biosciences Institute, Newcastle University , Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH